Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2022
DOI: 10.3389/fonc.2022.792297
|View full text |Cite
|
Sign up to set email alerts
|

Genomic and Molecular Signatures of Successful Patient-Derived Xenografts for Oral Cavity Squamous Cell Carcinoma

Abstract: BackgroundOral cavity squamous cell carcinoma (OSCC) is an aggressive malignant tumor with high recurrence and poor prognosis in the advanced stage. Patient-derived xenografts (PDXs) serve as powerful preclinical platforms for drug testing and precision medicine for cancer therapy. We assess which molecular signatures affect tumor engraftment ability and tumor growth rate in OSCC PDXs.MethodsTreatment-naïve OSCC primary tumors were collected for PDX models establishment. Comprehensive genomic analysis, includi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 34 publications
(33 reference statements)
0
2
0
Order By: Relevance
“…It has been proved that the essential characteristics of the “donor” tumor will be retained in PDX through mouse-to-mouse passage in vivo. DNA mutations and CNVs in PDX models were highly matched with the primary tumors (Yen et al 2022). Besides the genetic signature, PDX models also present similar biological behaviors to their human counterparts.…”
Section: Transplanted Mouse Model (Xenograft Mouse Models)mentioning
confidence: 96%
“…It has been proved that the essential characteristics of the “donor” tumor will be retained in PDX through mouse-to-mouse passage in vivo. DNA mutations and CNVs in PDX models were highly matched with the primary tumors (Yen et al 2022). Besides the genetic signature, PDX models also present similar biological behaviors to their human counterparts.…”
Section: Transplanted Mouse Model (Xenograft Mouse Models)mentioning
confidence: 96%
“…In a study by Yen et al, several PDX models of oral squamous cell carcinoma (OSCC) were established and pair-characterised with their primary tumours by WES and RNA-seq, showing that PDX strains are able to maintain most of the genetic mutations from the primary tumour. This study, which is however very recent and has yet to report the validation cohort, has also offered a gene expression profile of five genes ( MMP1 , FBLN5 , COL5A3 , BGN and LOXL1 ) that can predict successful xenograft engraftment [ 48 ].…”
Section: Hnscc In Vivo Modelsmentioning
confidence: 99%